Garje R - Search Results

1

Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)-Their Incidence, Management, Multiorgan irAEs, and Rechallenge.

Vaddepally R, Doddamani R, Sodavarapu S, Madam NR, Katkar R, Kutadi AP, Mathew N, Garje R, Chandra AB. Vaddepally R, et al. Among authors: garje r. Biomedicines. 2022 Mar 28;10(4):790. doi: 10.3390/biomedicines10040790. Biomedicines. 2022. PMID: 35453540 Free PMC article. Review.

2

Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration.

Dorff T, Zengin Z, Henderson N, Ali A, Nguyen C, Hwang C, Barata PC, Bilen M, Graham L, Mo G, Kilari D, Tripathi A, Labriola M, Rothstein S, Garje R, Koshkin V, Patel V, Schweizer M, Armstrong A, McKay R, Alva A. Dorff T, et al. Among authors: garje r. Res Sq [Preprint]. 2023 Aug 10:rs.3.rs-3201150. doi: 10.21203/rs.3.rs-3201150/v1. Res Sq. 2023. PMID: 37609284 Free PMC article. Updated. Preprint.

3

The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma.

Garje R, An J, Greco A, Vaddepally RK, Zakharia Y. Garje R, et al. Cancers (Basel). 2020 Jan 7;12(1):143. doi: 10.3390/cancers12010143. Cancers (Basel). 2020. PMID: 31936065 Free PMC article. Review.

4

PARP Inhibitors in Prostate and Urothelial Cancers.

Garje R, Vaddepally RK, Zakharia Y. Garje R, et al. Front Oncol. 2020 Feb 7;10:114. doi: 10.3389/fonc.2020.00114. eCollection 2020. Front Oncol. 2020. PMID: 32117762 Free PMC article. Review.

5

Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence.

Vaddepally RK, Kharel P, Pandey R, Garje R, Chandra AB. Vaddepally RK, et al. Among authors: garje r. Cancers (Basel). 2020 Mar 20;12(3):738. doi: 10.3390/cancers12030738. Cancers (Basel). 2020. PMID: 32245016 Free PMC article. Review.

6

Kaur A, Doberstein T, Amberker RR, Garje R, Field EH, Singh N. Kaur A, et al. Among authors: garje r. Medicine (Baltimore). 2019 Oct;98(41):e17348. doi: 10.1097/MD.0000000000017348. Medicine (Baltimore). 2019. PMID: 31593084 Free PMC article.

7

Evaluation of Checkpoint Inhibitors in Cancer Patients With End-stage Renal Disease on Hemodialysis: Case Series and Review of the Literature.

Jain J, Stein J, Garje R. Jain J, et al. Among authors: garje r. J Immunother. 2020 Oct;43(8):244-249. doi: 10.1097/CJI.0000000000000327. J Immunother. 2020. PMID: 32898386 Review.

8

Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.

Garje R, Chau JJ, Chung J, Wanat K, Zakharia Y. Garje R, et al. J Immunother. 2018 Jan;41(1):42-44. doi: 10.1097/CJI.0000000000000191. J Immunother. 2018. PMID: 29111983 Free PMC article.

9

Dabigatran-related leukocytoclastic vasculitis.

An J, Garje R, Wanat KA, Leone JP. An J, et al. Among authors: garje r. BMJ Case Rep. 2017 Jan 4;2017:bcr2016217423. doi: 10.1136/bcr-2016-217423. BMJ Case Rep. 2017. PMID: 28052946 Free PMC article.

10

Non-Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible.

Frydenlund N, Zakharia Y, Garje R, Dahmoush L, O'Donnell MA. Frydenlund N, et al. Among authors: garje r. J Investig Med High Impact Case Rep. 2018 Oct 16;6:2324709618806332. doi: 10.1177/2324709618806332. eCollection 2018 Jan-Dec. J Investig Med High Impact Case Rep. 2018. PMID: 30349834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page